Latest Articles
- Aspirin for primary prevention of cardiovascular disease: What do the current USPSTF guidelines say?
A concise overview of the US Preventive Services Task Force recommendations.
- Cholesteatoma
The patient’s audiogram showed left-sided conductive hearing loss, and examination revealed an atelectatic tympanic membrane on the left with a retraction pocket and keratin debris.
Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and managementA review of the incidence and severity of each immune checkpoint inhibitor-related endocrinopathy, factors related to toxicity risk, and principles of management.
- Aspirin in primary prevention of cardiovascular events: Key questions remain
Are we done with the issue of aspirin in primary prevention? Not quite yet.
- What is the optimal approach to infiltration and extravasation of nonchemotherapy medications?
The immediate response is warm or cold compression and assessment of the severity.
- Chronic centralized pain syndromes: A rheumatologist’s perspective
Centralized pain syndromes are vexing for patients and clinicians. In this issue, Volcheck and colleagues present a framework for understanding chronic centralized pain and for developing an actionable treatment plan for patients.
- Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome
A review of recommendations from the American Association for the Study of Liver Diseases.
- Central sensitization, chronic pain, and other symptoms: Better understanding, better management
Clinicians have a pivotal role by providing patient education, which can affect perception, management, functional status, and quality of life.
- Heart failure with reduced ejection fraction: What’s new in the 2022 guideline?
Evidence-based and guideline-based medical therapies can help patients feel better, stay out of the hospital, live longer, and potentially improve left ventricular function.
